Itraconazole 130mg capsules formulated with SUBA™ (Super BioAvailable) Technology are an advanced antifungal medication designed to provide enhanced absorption and improved therapeutic effectiveness. SUBA technology improves the bioavailability of Itraconazole compared to conventional formulations, ensuring more consistent plasma levels and better clinical outcomes. Itraconazole is a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections affecting the skin, nails, lungs, and systemic organs. It works by inhibiting fungal cell membrane synthesis through blocking ergosterol production, leading to fungal cell death. This formulation is commonly prescribed for: Dermatophytosis (Ringworm) Onychomycosis (Fungal nail infection) Aspergillosis Blastomycosis Histoplasmosis Candidiasis (Non-invasive forms) The SUBA formulation ensures: Improved gastrointestinal absorption Reduced variability in drug levels Better patient compliance Enhanced therapeutic response
